骨粘連蛋白(ON)多克隆抗體(異硫氰酸熒光素標(biāo)記)
FITC-Linked Polyclonal Antibody to Osteonectin (ON)
SPARC; BM-40; Secreted Protein,Acidic,Cysteine-Rich; Basement-membrane protein 40; Secreted protein acidic and rich in cysteine
- 編號LAA791Hu81
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源抗體標(biāo)記
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物熒光素
- 原抗體 PAA791Hu01-骨粘連蛋白(ON)多克隆抗體
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IF.
如果抗體需用于流式細(xì)胞術(shù),請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 790 ¥ 1844 ¥ 2634 ¥ 6585 ¥ 26340
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對ON的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別ON。
用法
Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA791Hu01 | 骨粘連蛋白(ON)活性蛋白 | Cell?culture;?Activity?Assays. |
EPA791Hu61 | 骨粘連蛋白(ON)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA791Hu61 | 骨粘連蛋白(ON)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA791Hu01 | 骨粘連蛋白(ON)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
CPA791Hu21 | 骨粘連蛋白(ON)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
PAA791Hu01 | 骨粘連蛋白(ON)多克隆抗體 | WB; IHC; ICC; IP. |
PAA791Hu08 | 骨粘連蛋白(ON)多克隆抗體 | WB; IHC; ICC; IP. |
LAA791Hu81 | 骨粘連蛋白(ON)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
LAA791Hu71 | 骨粘連蛋白(ON)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA791Hu22 | 骨粘連蛋白(ON)單克隆抗體 | WB; IHC; ICC; IP. |
SEA791Hu | 骨粘連蛋白(ON)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA791Hu | 骨粘連蛋白(ON)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA791Hu01 | 骨粘連蛋白(ON)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
J Mol Med (Berl) | Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance [PubMed: 26199111] |
Muscle Nerve | Effect of resistance ladder training on SPARC expression in skeletal muscle of hindlimb immobilized rats [PubMed: 26467437] |
Medicine (Baltimore) | An Attempt to Evaluate Selected Aspects of “Bone–Fat Axis” Function in Healthy Individuals and Patients With Pancreatic Cancer [PubMed: 26266370] |
British Journal of Cancer | A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma [Pubmed:26889976] |
Journal of diabetes and its complications | Associations between FGF21, osteonectin and bone turnover markers in type 2 diabetic patients with albuminuria. [pubmed:27916484] |
American journal of the medical sciences | Association of Bone Metabolic Markers With Diabetic Retinopathy and Diabetic Macular Edema in Elderly Chinese Individuals With Type 2 Diabetes Mellitus [pubmed:29078839] |
Translational Research in Oral Oncology | Testican 1 (SPOCK1) and protein tyrosine phosphatase, receptor type S (PTPRS) show significant increase in saliva of tobacco users with oral cancer [Doi: 10.1177/2057178X18800534] |
[ENGINEERING OF BIOMATERIALS | Osteoconductive potential of PLGA/bioglass composite biomaterials [] |
留言咨詢